Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AHSP as a Biomarker of Sickle Cell Disease
NCT06735625Recruiting
- Sponsor
- Centre hospitalier de Saint-Denis
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Trial (4 arms), sponsored by Centre hospitalier de Saint-Denis. Primary endpoint: AHSP concentrations measured in patients at 6 months. Started Mar 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06735625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06735625.